Teleflex (NYSE:TFX) and DarioHealth (NASDAQ:DRIO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Analyst Ratings

This is a summary of current ratings and target prices for Teleflex and DarioHealth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex 0 3 4 1 2.75
DarioHealth 0 0 1 0 3.00

Teleflex presently has a consensus target price of $297.00, suggesting a potential upside of 3.29%. Given Teleflex’s higher probable upside, equities research analysts plainly believe Teleflex is more favorable than DarioHealth.

Dividends

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 0.5%. DarioHealth does not pay a dividend. Teleflex pays out 13.7% of its earnings in the form of a dividend.

Profitability

This table compares Teleflex and DarioHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Teleflex 8.20% 18.47% 7.43%
DarioHealth -343.72% -386.47% -255.38%

Insider & Institutional Ownership

91.6% of Teleflex shares are held by institutional investors. Comparatively, 7.8% of DarioHealth shares are held by institutional investors. 2.6% of Teleflex shares are held by company insiders. Comparatively, 22.7% of DarioHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Teleflex has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of -1.36, suggesting that its share price is 236% less volatile than the S&P 500.

Valuation and Earnings

This table compares Teleflex and DarioHealth’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teleflex $2.45 billion 5.40 $152.53 million $9.90 29.05
DarioHealth $5.17 million 4.62 -$15.74 million N/A N/A

Teleflex has higher revenue and earnings than DarioHealth.

Summary

Teleflex beats DarioHealth on 12 of the 15 factors compared between the two stocks.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

DarioHealth Company Profile

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications, and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy and distributors; and through e-stores. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.